FDA cancer leader Harpreet Singh departs for CRO role
FDA oncology division director Harpreet Singh, M.D., has left the agency to join Precision for Medicine as chief medical officer.
Source: fiercebiotech.com
Stay updated with breaking news from Project Pragmatica. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA oncology division director Harpreet Singh, M.D., has left the agency to join Precision for Medicine as chief medical officer.
A new report by Cure4Cancer on how enhancing clinical trial access can save millions of lives from cancer.